A D S Diagnostics Ltd
A D S Diagnostics Ltd (ADSDIAG) last reported results for the quarter ended Jun 2026, with sales of ₹3.51 crore and net profit of ₹0.03 crore. The stock last traded at ₹11.3, a market capitalisation of ₹0 crore. Figures are as of 9 Oct 2026 and are not real time.
A D S Diagnostics Ltd share price and key metrics
- Current price
- ₹11.3
- Market cap
- ₹0 cr
- Book value
- ₹34
- ROE
- 15.2%
- ROCE
- 21.1%
- Dividend yield
- 10.6%
- 52w high / low
- /
Metrics as of 9 Oct 2026. Not real time.
Track A D S Diagnostics Ltd
Cruxal reads every A D S Diagnostics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
A D S Diagnostics Ltd growth and returns
- 10 Years
- 9%
- 5 Years
- 25%
- 3 Years
- 29%
- TTM
- 69%
- 10 Years
- 8%
- 5 Years
- 26%
- 3 Years
- 2%
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- 16%
- 5 Years
- 19%
- 3 Years
- 20%
- Last Year
- 15%
A D S Diagnostics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹3.51 cr, down 20.2% from ₹4.4 cr a year earlier. Net profit was ₹0.03 cr, down 80.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 5.96 | 2.6 | 3.37 | 4.4 | 14.59 | 5.46 | 4.04 | 3.51 |
| Expenses | 5.18 | 2.23 | 3.16 | 4.05 | 13.57 | 5 | 3.76 | 3.36 |
| Operating profit | 0.78 | 0.37 | 0.21 | 0.35 | 1.02 | 0.46 | 0.28 | 0.15 |
| OPM % | 13.09% | 14.23% | 6.23% | 7.95% | 6.99% | 8.42% | 6.93% | 4.27% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0.12 | 0.08 | 0.06 | 0.12 | 0.18 | 0.18 | 0.13 | 0.1 |
| Depreciation | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | -0.02 | 0.01 |
| Profit before tax | 0.62 | 0.25 | 0.12 | 0.2 | 0.81 | 0.26 | 0.17 | 0.04 |
| Tax % | 24.19% | 24.00% | 41.67% | 25.00% | 25.93% | 23.08% | 35.29% | 25.00% |
| Net profit | 0.47 | 0.19 | 0.07 | 0.15 | 0.61 | 0.2 | 0.12 | 0.03 |
| EPS (₹) | 2.14 | 0.87 | 0.32 | 0.68 | 2.78 | 0.91 | 0.55 | 0.14 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
A D S Diagnostics Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.26 | 6.38 | 8.95 | 13.52 | 9.43 | 10.1 | 13.29 | 23.96 | 16 | 28.49 | 27.6 |
| Operating profit | -0.75 | 0.73 | 1.54 | 0.56 | 0.1 | 0.99 | 1.5 | 3.13 | 1.4 | 2.11 | 1.91 |
| OPM % | -14.26% | 11.44% | 17.21% | 4.14% | 1.06% | 9.80% | 11.29% | 13.06% | 8.75% | 7.41% | 6.92% |
| Net profit | -0.52 | 0.21 | 0.85 | 0.47 | 0.34 | 0.44 | 0.41 | 1.85 | 0.81 | 1.07 | 0.96 |
| EPS (₹) | -2.37 | 0.96 | 3.88 | 2.14 | 1.55 | 2.01 | 1.87 | 8.44 | 3.69 | 4.88 | 4.38 |
TTM is the trailing twelve months to the most recent quarter.
A D S Diagnostics Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 | 2.25 |
| Reserves | -0.31 | -0.10 | 0.77 | 1.07 | 1.41 | 1.85 | 2.13 | 3.77 | 4.34 | 5.20 |
| Borrowings | 4.19 | 3.79 | 1.81 | 5.51 | 5.29 | 3.99 | 2.54 | 2.08 | 2.31 | 3.10 |
| Other liabilities | 2.35 | 4.18 | 11.93 | 8.54 | 5.63 | 3.92 | 5.05 | 7.83 | 10.25 | 12.31 |
| Total liabilities | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |
| Fixed assets | 1.38 | 1.11 | 2.10 | 1.84 | 1.55 | 1.15 | 0.37 | 0.22 | 0.26 | 0.28 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Other assets | 7.06 | 8.97 | 14.62 | 15.49 | 12.99 | 10.82 | 11.56 | 15.67 | 18.85 | 22.54 |
| Total assets | 8.48 | 10.12 | 16.76 | 17.37 | 14.58 | 12.01 | 11.97 | 15.93 | 19.15 | 22.86 |
As reported by the company. Total assets equal total liabilities by construction.
A D S Diagnostics Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.60 | 0.89 | 3.82 | -3.98 | 0.53 | 1.74 | 1.44 | 1.99 | 0.78 | -0.04 |
| Cash from investing | 0.62 | 0.15 | -1.07 | 0.08 | 0.09 | 0.24 | 0.68 | 0.06 | -0.12 | 0.06 |
| Cash from financing | 1.13 | 0.09 | -2.35 | 2.83 | -0.09 | -2.00 | -3.18 | -1.22 | -0.34 | -0.04 |
| Net cash flow | 0.15 | 1.13 | 0.41 | -1.07 | 0.53 | -0.03 | -1.06 | 0.83 | 0.31 | -0.02 |
| Free cash flow | -1.46 | 0.93 | 2.67 | -3.99 | 0.52 | 1.91 | 2.06 | 1.98 | 0.57 | -0.11 |
| CFO / operating profit | 191% | 127% | 260% | -684% | 530% | 187% | 113% | 79% | 97% | 13% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
A D S Diagnostics Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -0.77% | 15.74% | 28.97% | 16.11% | 11.25% | 12.09% | 23.85% | 40.88% | 16.24% | 21.09% |
| Debtor days | 136.01 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 75.53 | 78.76 | 98.09 | 63.67 |
| Inventory days | 283.74 | — | — | — | — | — | 280.52 | 186.28 | 468.76 | 279.14 |
| Days payable | 161.19 | — | — | — | — | — | 171.67 | 79.83 | 382.21 | 173.69 |
| Cash conversion cycle | 258.56 | 127.01 | 106.44 | 137.68 | 174.57 | 123.59 | 184.38 | 185.20 | 184.65 | 169.12 |
| Working capital days | -4.86 | 0.57 | -30.99 | 25.38 | 58.83 | 57.10 | 74.70 | 67.33 | 102.20 | 61.11 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
A D S Diagnostics Ltd shareholding pattern
Promoters held 45.39% at Jun 2026, broadly unchanged since Jun 2025. DIIs 4.57%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% | 45.39% |
| DIIs | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% | 4.57% |
| Public | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% | 50.03% |
| No. of shareholders | 5,513 | 5,513 | 5,513 | 5,513 | 5,513 | 5,513 | 5,513 | 5,513 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
A D S Diagnostics Ltd corporate filings
- ADS Diagnostic Limited conducts highly significant shareholder approvals at its 41st AGM, including re-appointments of key independent directors and secretarial auditor, with over 94% voting in favor on key resolutions, indicating strong investor support.AGM/EGMhigh impact
Cruxal's analysis: ADS Diagnostic Limited, a small-cap company with a market cap of approximately 2.55 crore…
Read the full analysis - List of Proceedings of Annual General Meeting of the Company held today i.e. September 29, 2026 is attached.AGM/EGMmedium impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.